Biopharma eyes $100M for crypto treasury to back cancer treatment
Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Propanc Biopharma said it will build a crypto treasury after securing up to $100 million from Hexstone Capital to further its potential cancer treatment and reignite investor interest.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
NEAR Intents’ General Manager Says Part of the $3.8 Million Exploit Came Back in Monero
The attacker who drained about $3.8 million from NEAR Intents returned only part of it in Bitcoin, the protocol’s general manager...
Bitcoin Claws Back $2,500 Overnight After a $771 Million Crypto Liquidation Wave
Bitcoin traded near $83,700 early Tuesday, up from a low of about $81,200 at 00:50 UTC, CoinGecko prices show. The recovery came w...
Bitcoin’s quantum-safe protection gets 82% cheaper as researchers race to secure 6 million exposed BTC
Researchers have cut the estimated computing cost of a specialized quantum-safe Bitcoin transaction by 82% to $59. Data from the Q...
Strategy spent nearly nine times as much on STRC buybacks as Bitcoin last week
Strategy (formerly MicroStrategy) bought 250 Bitcoin for $21.5 million last week while spending $192.4 million to repurchase its S...
FTX’s former Bitcoin mining bet gets new life as parent raises €800 million for AI
SWI Group has raised €800 million to expand AI infrastructure, advancing its plan to repurpose FTX-backed Bitcoin miner Genesis Di...
Australia moves to close crypto derivatives loophole after retail traders lose A$458 million
Australia's markets regulator proposed extending retail leverage restrictions to crypto-settled derivatives amid mounting losses a...